Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they ...

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

The sell-off started last night and continued in after-hours trading after the New York-based biopharma company revealed that ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Great Place to Work, Built Ins: Top Biotech Companies 2024, Forbes Best Places to Work in Life Sciences are joining our LEAP ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met.

The use of specialty drugs in the U.S. has skyrocketed in recent years driven primarily by an increase in chronic condition diagnosis and the number of new medications on the market. Krishnanjan ...

Join biotech commentators Daphne Zohar, Josh Schimmer, and Brad Loncar for a weekly discussion of all things biotech. From emerging trends and investment opportunities to the challenges facing the ...